Fig. 2From: Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)Schedule of enrolment, interventions, and assessments in accordance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT). #Only performed in the patients enrolled at Herlev-Gentofte Hospital. *Only performed in a sub-group of the patients enrolled at Odense University Hospital. ECG electrocardiogram, OGTT oral glucose tolerance test, DXA dual-energy X-ray absorptiometry, 51Cr-EDTA chromium-51 labeled ethylenediamine tetra-acetic acid. AE adverse event, SAE severe adverse event, IP investigational productBack to article page